These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 28086886

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice.
    Zhang Y, Pan SY, Zhou SF, Wang XY, Sun N, Zhu PL, Chu ZS, Yu ZL, Ko KM.
    Drug Des Devel Ther; 2014; 8():1429-39. PubMed ID: 25278745
    [Abstract] [Full Text] [Related]

  • 3. Effective kinetics of schisandrin B on serum/hepatic triglyceride and total cholesterol levels in mice with and without the influence of fenofibrate.
    Pan SY, Dong H, Guo BF, Zhang Y, Yu ZL, Fong WF, Han YF, Ko KM.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):585-91. PubMed ID: 21523558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel mouse model of combined hyperlipidemia associated with steatosis and liver injury by a single-dose intragastric administration of schisandrin B/cholesterol/bile salts mixture.
    Pan SY, Jia ZH, Zhang Y, Yu Q, Wang XY, Sun N, Zhu PL, Yu ZL, Ko KM.
    J Pharmacol Sci; 2013 Jun; 123(2):110-9. PubMed ID: 24096833
    [Abstract] [Full Text] [Related]

  • 6. A novel experimental model of acute hypertriglyceridemia induced by schisandrin B.
    Pan SY, Dong H, Han YF, Li WY, Zhao XY, Ko KM.
    Eur J Pharmacol; 2006 May 10; 537(1-3):200-4. PubMed ID: 16624278
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.
    Chu JH, Wang H, Ye Y, Chan PK, Pan SY, Fong WF, Yu ZL.
    World J Gastroenterol; 2011 May 21; 17(19):2379-88. PubMed ID: 21633637
    [Abstract] [Full Text] [Related]

  • 8. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
    Jeong MJ, Kim SR, Jung UJ.
    Nutr Res; 2019 Apr 21; 64():64-71. PubMed ID: 30802724
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice.
    Chu ZS, Yu ZL, Pan SY, Jia ZH, Wang XY, Zhang Y, Zhu PL, Wang XJ, Ko KM.
    Lipids Health Dis; 2015 Aug 25; 14():93. PubMed ID: 26303027
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Schisandrin B regulates lipid metabolism in subcutaneous adipocytes.
    Kwan HY, Wu J, Su T, Chao XJ, Yu H, Liu B, Fu X, Tse AKW, Chan CL, Fong WF, Yu ZL.
    Sci Rep; 2017 Aug 31; 7(1):10266. PubMed ID: 28860616
    [Abstract] [Full Text] [Related]

  • 13. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
    Yan LS, Zhang SF, Luo G, Cheng BC, Zhang C, Wang YW, Qiu XY, Zhou XH, Wang QG, Song XL, Pan SY, Zhang Y.
    Metabolism; 2022 Jun 31; 131():155200. PubMed ID: 35405150
    [Abstract] [Full Text] [Related]

  • 14. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF, Purushotham A, Wendel AA, Belury MA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun 31; 292(6):G1671-82. PubMed ID: 17322064
    [Abstract] [Full Text] [Related]

  • 15. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.
    Metabolism; 2013 Nov 31; 62(11):1651-61. PubMed ID: 23928105
    [Abstract] [Full Text] [Related]

  • 16. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
    den Boer MA, Berbée JF, Reiss P, van der Valk M, Voshol PJ, Kuipers F, Havekes LM, Rensen PC, Romijn JA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 31; 26(1):124-9. PubMed ID: 16269669
    [Abstract] [Full Text] [Related]

  • 17. Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease.
    Leong PK, Ko KM.
    Oxid Med Cell Longev; 2016 Jan 31; 2016():6171658. PubMed ID: 27847552
    [Abstract] [Full Text] [Related]

  • 18. Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice.
    Jung HR, Turner SM, Neese RA, Young SG, Hellerstein MK.
    Biochem J; 1999 Oct 15; 343 Pt 2(Pt 2):473-8. PubMed ID: 10510316
    [Abstract] [Full Text] [Related]

  • 19. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice.
    Lian J, Wei E, Wang SP, Quiroga AD, Li L, Di Pardo A, van der Veen J, Sipione S, Mitchell GA, Lehner R.
    Hepatology; 2012 Dec 15; 56(6):2154-62. PubMed ID: 22707181
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of schisandrin B and dimethyl diphenyl bicarboxylate (DDB) on hepatic mitochondrial glutathione redox status in carbon tetrachloride intoxicated mice.
    Ip SP, Yiu HY, Ko KM.
    Mol Cell Biochem; 2000 Feb 15; 205(1-2):111-4. PubMed ID: 10821428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.